CVA Family Office’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
CVA Family Office's ELV Position: Q2 2026 in Review
CVA Family Office increased its Elevance Health (ELV) stake by 2.6% in Q2 2026, buying an estimated $6.67K and bringing the position to 722 shares worth $279K. The position accounts for 0.03% of the portfolio, ranked #284.
CVA Family Office first reported a position in ELV in Q1 2020 and has held it in 26 quarters since. The position peaked at $326K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- CVA Family Office held 722 shares of Elevance Health worth $279K as of Q2 2026.
- CVA Family Office bought 18 Elevance Health shares in Q2 2026, an estimated $6.67K.
- Elevance Health made up 0.03% of CVA Family Office's portfolio in Q2 2026, its #284 holding.
- CVA Family Office first reported a position in Elevance Health in Q1 2020 and has held it in 26 quarters since.
- CVA Family Office's Elevance Health position peaked at $326K in Q2 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.